, a provider of clinical research to drug developers with a market value of $4 billion, people familiar with the matter said.
Bloomberg News first reported the news of the investment consortium's talks with Syneos. Shares of Syneos were up about 19% in after-market trading. Syneos, which carries a debt pile of nearly $3 billion, was created in 2017 by INC Research Holdings Inc's acquisition of inVentiv Health Inc for $7.4 billion, including debt.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Business Business Latest News, Business Business Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Australia's biggest pension funds raise investment in fossil fuels, activist group saysAustralia's 30 biggest pension funds in 2022 raised their investment to more than A$34 billion ($23 billion) in companies most responsible for expanding fossil fuels, environmental activist group Market Forces said.
Source: ReutersScience - 🏆 559. / 51 Read more »
US weighs restrictions on investment in Chinese AI firmsThe U.S. government is planning an outbound investment screening mechanism that would potentially review overseas investments in sensitive technologies, including Chinese AI firms.
Source: FoxBusiness - 🏆 458. / 53 Read more »
Sen. Ossoff, EPA leadership announce $4 billion investment in clean energy at US portsU.S. environmental leaders joined Sen Jon Ossoff in Savannah Friday afternoon to announce a historic $4 billion investment in clean energy infrastructure at U.S. ports and in the logistics industry.
Source: wsyx6 - 🏆 444. / 53 Read more »